With his distinctive background as a renowned Pharmacologist and many years of experience as a Lecturer and Medical Advisor in the US and some Middle Eastern countries, Dr. Afrane relates well to DAS Plc’s vision of becoming an internationally recognized and a leading brand in the delivery of health needs.

Dr. Afrane is currently a Non-Executive Board Member of Dannex Ayrton Starwin Plc. Prior to this, he served as a Board member of Dannex Ltd from 2011 to 2019.

In his contribution to the Board, Dr. Afrane seeks to bring a wealth of his experience in the design of solution to matters of pharmaceutical innovation and application.

Currently, Dr. Afrane is Dean at Entrance University College of Health Sciences. He was previously a Senior Lecturer and Head of Department at the University Of Ghana School Of Pharmacy. He holds a PharmD Degree from the University of Southern California and a Degree in Chemistry from the University of New York.